• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Clearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of Enfusion

    2/26/25 7:14:00 PM ET
    $CWAN
    $ENFN
    Computer Software: Prepackaged Software
    Technology
    Computer Software: Prepackaged Software
    Technology
    Get the next $CWAN alert in real time by email

    Clearwater Analytics Holdings, Inc. (NYSE:CWAN) ("Clearwater" or the "Company"), a leading worldwide provider of SaaS-based investment management, accounting, reporting, and analytics solutions, and Enfusion, Inc. (NYSE:ENFN) ("Enfusion"), a leader in software-as-a-service solutions for the investment management and hedge fund industry, today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act"), in connection with Clearwater's previously announced proposed acquisition of Enfusion. The expiration of the waiting period occurred at 11:59 p.m. on February 24, 2025.

    The expiration of the waiting period under the HSR Act satisfies one of the closing conditions for the completion of the transaction.

    The transaction is expected to close in the second quarter of 2025, subject to the satisfaction or waiver of customary closing conditions including the receipt of Enfusion shareholder approval.

    About Clearwater Analytics

    Clearwater Analytics (NYSE:CWAN), a global, industry-leading SaaS solution, automates the entire investment lifecycle. With a single instance, multi-tenant architecture, Clearwater offers award-winning investment portfolio planning, performance reporting, data aggregation, reconciliation, accounting, compliance, risk, and order management. Each day, leading insurers, asset managers, corporations, and governments use Clearwater's trusted data to drive efficient, scalable investing on more than $8.8 trillion in assets spanning traditional and alternative asset types. Additional information about Clearwater can be found at clearwateranalytics.com.

    About Enfusion

    Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over 850 investment managers from 9 global offices spanning four continents. For more information, please visit www.enfusion.com.

    Use of Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the beliefs and assumptions of Clearwater's and Enfusion's management and on information currently available to them. Forward-looking statements include information concerning the following factors in reference to Clearwater and/or Enfusion: the timing of the consummation of the acquisition and the ability to satisfy closing conditions, possible or assumed future results of operations, possible or assumed performance, business strategies, technology developments, financing and investment plans, competitive position, industry, economic and regulatory environment, potential growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "aim," "may," "plan," "potential," "predict," "project," "seek," "should," "will," "would" or similar expressions and the negatives of those terms, but are not the exclusive means of identifying such statements.

    Forward-looking statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond Clearwater's and Enfusion's control, that may cause their actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the ability to successfully close the acquisition, Clearwater's ability to successfully integrate the operations and technology of Enfusion with those of Clearwater, retain and incentivize the employees of Enfusion following the close of the acquisition, retain Enfusion's clients, repay debt to be incurred in connection with the Enfusion acquisition and meet financial covenants to be imposed in connection with such debt, risks that cost savings, synergies and growth from the acquisition may not be fully realized or may take longer to realize than expected, as well as other risks and uncertainties discussed under "Risk Factors" in Clearwater's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the US Securities and Exchange Commission (the "SEC") on February 26, 2025 and in Enfusion's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 12, 2024, those discussed under "Risk Factors" in Enfusion's Annual Report on Form 10-K for the year ended December 31, 2024 that will be filed following this press release, as well as in other periodic reports filed by Clearwater and Enfusion with the SEC. These filings are available at www.sec.gov and on Clearwater's website, investors.clearwateranalytics.com, and Enfusion's website, ir.enfusion.com. Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent management's beliefs and assumptions only as of the date of this press release and should not be relied upon as representing Clearwater's or Enfusion's expectations or beliefs as of any date subsequent to the time they are made. Each of Clearwater and Enfusion does not undertake to and specifically declines any obligation to update any forward-looking statements that may be made from time to time by or on behalf of Clearwater or Enfusion.

    No Offer or Solicitation

    This press release is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the "Securities Act").

    Additional Information and Where to Find It

    In connection with the acquisition, Clearwater has filed with the SEC a Registration Statement on Form S-4 (the "Registration Statement") to register the shares of Clearwater's common stock to be issued pursuant to the acquisition, which constitutes a prospectus of Clearwater and a proxy statement of Enfusion (the "proxy statement/prospectus"). Each of Clearwater and Enfusion may also file other documents with the SEC regarding the acquisition. This press release is not a substitute for the Registration Statement, proxy statement/prospectus or any other document which Clearwater or Enfusion may file with the SEC in connection with the acquisition. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TRANSACTION, THE RISKS RELATED THERETO, AND RELATED MATTERS. After the Registration Statement has been declared effective, the definitive proxy statement/prospectus (if and when available) will be mailed to Enfusion's security holders. Investors and security holders will be able to obtain free copies of the Registration Statement and proxy statement/prospectus, as each may be amended or supplemented from time to time, and other relevant documents filed by Clearwater and Enfusion with the SEC (if and when available) through the website maintained by the SEC at www.sec.gov. Copies of documents filed with the SEC by Clearwater, including the proxy statement/prospectus will be available free of charge from Clearwater's website at investors.clearwateranalytics.com/overview. Copies of documents filed with the SEC by Enfusion, including the proxy statement/prospectus will be available free of charge from Enfusion's website at ir.enfusion.com.

    Participants in the Solicitation

    Clearwater, Enfusion and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the Transaction. Information about Clearwater's directors and executive officers is available in Clearwater's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 26, 2025, its definitive proxy statement for its 2024 annual meeting of stockholders, which was filed with the SEC on April 29, 2024, and in the proxy statement/prospectus. Information about the directors and executive officers of Enfusion is available in its Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 12, 2024, its Annual Report on Form 10-K for the year ended December 31, 2024 that will be filed following this press release, its definitive proxy statement for its 2024 annual meeting of stockholders, which was filed with the SEC on April 26, 2024, and in the proxy statement/prospectus. Other information regarding the participants in the solicitations and a description of their direct and indirect interests, by security holdings or otherwise, are or will be contained in the Registration Statement, the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the Transaction when they become available. Investors should read the proxy statement/prospectus carefully before making any voting or investment decisions. Copies of the documents filed with the SEC by Clearwater and Enfusion will be available free of charge through the website maintained by the SEC at www.sec.gov. Additionally, copies of documents filed with the SEC by Clearwater, including the proxy statement/prospectus will be available free of charge from Clearwater's website at investors.clearwateranalytics.com/overview, and copies of documents filed with the SEC by Enfusion, including the proxy statement/prospectus will be available free of charge from Enfusion's website at ir.enfusion.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250226851041/en/

    Investor Contact for Clearwater Analytics

    Joon Park | +1 415-906-9242 | [email protected]

    Investor Contact for Enfusion

    Bill Wright | [email protected]

    Media Contact for Clearwater Analytics

    Claudia Cahill | +1 703-728-1221 | [email protected]

    Media Contact for Enfusion

    Mollie Applegate | [email protected]

    Get the next $CWAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CWAN
    $ENFN

    CompanyDatePrice TargetRatingAnalyst
    Clearwater Analytics Holdings Inc.
    $CWAN
    4/25/2025$28.00Overweight
    Analyst
    Clearwater Analytics Holdings Inc.
    $CWAN
    2/20/2025$28.00 → $36.00Neutral → Overweight
    Piper Sandler
    Clearwater Analytics Holdings Inc.
    $CWAN
    1/17/2025$30.00 → $34.00Equal-Weight → Overweight
    Morgan Stanley
    Clearwater Analytics Holdings Inc.
    $CWAN
    1/14/2025$35.00 → $32.00Neutral → Buy
    DA Davidson
    Clearwater Analytics Holdings Inc.
    $CWAN
    11/8/2024$31.00 → $35.00Buy → Neutral
    DA Davidson
    Clearwater Analytics Holdings Inc.
    $CWAN
    11/7/2024$23.00 → $33.00Neutral → Overweight
    JP Morgan
    Clearwater Analytics Holdings Inc.
    $CWAN
    8/19/2024$28.00Buy
    Citigroup
    Clearwater Analytics Holdings Inc.
    $CWAN
    7/8/2024$25.00Perform → Outperform
    Oppenheimer
    More analyst ratings

    $CWAN
    $ENFN
    Financials

    Live finance-specific insights

    See more
    • Clearwater Analytics Announces First Quarter 2025 Financial Results

      Record Quarterly Revenue of $126.9 Million, Up 24% Year-Over-Year Annualized Recurring Revenue of $493.9 Million, Up 23% Year-Over-Year Gross Revenue Retention Rate of 98%; Net Revenue Retention Rate of 114% Net Income of $6.9 Million Adjusted EBITDA of $45.1 Million, Up 40% Year-Over-Year Clearwater Analytics Holdings, Inc. (NYSE:CWAN) ("Clearwater Analytics" or the "Company"), the most comprehensive technology platform for investment management, today announced its financial results for the quarter ended March 31, 2025. "In Clearwater's final quarter prior to its acquisitions of Enfusion, Beacon and Bistro, I'm incredibly proud to report both exceptional results and milestone achiev

      4/30/25 4:15:00 PM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics Finalizes Acquisition of Enfusion

      Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

      4/21/25 4:15:00 PM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics to Announce First Quarter 2025 Financial Results on April 30, 2025

      Clearwater Analytics Holdings, Inc. (NYSE:CWAN), ("Clearwater Analytics" or the "Company"), a leading worldwide provider of SaaS-based investment management, accounting, reporting, and analytics solutions, will release financial results for the first quarter ended March 31, 2025 after the U.S. financial markets close on Wednesday, April 30, 2025. In conjunction with this announcement, Clearwater Analytics will host a conference call on April 30, 2025, at 5:00 p.m. ET through a live webcast available on the Company's investor relations website. Participants must visit investors.clearwateranalytics.com in advance to register, download, and install any necessary audio software. A replay of th

      4/16/25 4:15:00 PM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology

    $CWAN
    $ENFN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Iconiq Strategic Partners V, L.P. disposed of 9,009,594 shares (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:12 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Director Luo Roy returned 9,009,594 shares to the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:09 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Chief Operating Officer Pawar Neal returned 1,217,308 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/21/25 5:11:16 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $CWAN
    $ENFN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Clearwater Analytics Holdings Inc.

      SC 13G/A - Clearwater Analytics Holdings, Inc. (0001866368) (Subject)

      11/14/24 5:48:49 PM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13G/A filed by Clearwater Analytics Holdings Inc.

      SC 13G/A - Clearwater Analytics Holdings, Inc. (0001866368) (Subject)

      11/13/24 9:38:55 PM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13G/A filed by Clearwater Analytics Holdings Inc.

      SC 13G/A - Clearwater Analytics Holdings, Inc. (0001866368) (Subject)

      11/13/24 4:05:14 PM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology

    $CWAN
    $ENFN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Analyst resumed coverage on Clearwater Analytics with a new price target

      Analyst resumed coverage of Clearwater Analytics with a rating of Overweight and set a new price target of $28.00

      4/25/25 8:32:12 AM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Clearwater Analytics from Neutral to Overweight and set a new price target of $36.00 from $28.00 previously

      2/20/25 7:01:09 AM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Clearwater Analytics from Equal-Weight to Overweight and set a new price target of $34.00 from $30.00 previously

      1/17/25 7:34:00 AM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology

    $CWAN
    $ENFN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Wayne Cooperative Insurance Expands Clearwater Analytics Relationship with Risk and Performance Analytics Suite

      Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced that long-time client Wayne Cooperative Insurance has expanded its relationship with Clearwater to include performance attribution and risk analytics that drive improved returns and reduced risk exposure. Building on their successful use of Clearwater's core investment accounting and reporting platform, Wayne Cooperative Insurance will now enhance their investment operations with sophisticated risk and performance capabilities. Through advanced scenario simulations, the investment team can assess potential market events, including interest rate shifts, credit spread chang

      5/7/25 9:00:00 AM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics Announces First Quarter 2025 Financial Results

      Record Quarterly Revenue of $126.9 Million, Up 24% Year-Over-Year Annualized Recurring Revenue of $493.9 Million, Up 23% Year-Over-Year Gross Revenue Retention Rate of 98%; Net Revenue Retention Rate of 114% Net Income of $6.9 Million Adjusted EBITDA of $45.1 Million, Up 40% Year-Over-Year Clearwater Analytics Holdings, Inc. (NYSE:CWAN) ("Clearwater Analytics" or the "Company"), the most comprehensive technology platform for investment management, today announced its financial results for the quarter ended March 31, 2025. "In Clearwater's final quarter prior to its acquisitions of Enfusion, Beacon and Bistro, I'm incredibly proud to report both exceptional results and milestone achiev

      4/30/25 4:15:00 PM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics Completes Acquisition of Beacon, Deepening Risk and Modeling Capabilities

      Unified Platform to Deliver Full Investment Management Lifecycle—From Trading and Compliance to IBOR, Accounting, and Regulatory Reporting Across Jurisdictions Clearwater Analytics (NYSE:CWAN) ("Clearwater"), the most comprehensive technology platform for investment management, today announced it has completed its acquisition of Beacon Platform Inc. (Beacon), a provider of enterprise risk analytics and developer infrastructure. The acquisition strengthens Clearwater's capabilities in complex portfolio management across both public and private markets, including structured products, private credit, and derivatives. For years, institutional investors have faced a tradeoff between advanced a

      4/30/25 4:15:00 PM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology

    $CWAN
    $ENFN
    SEC Filings

    See more

    $CWAN
    $ENFN
    Leadership Updates

    Live Leadership Updates

    See more
    • SEC Form 10-Q filed by Clearwater Analytics Holdings Inc.

      10-Q - Clearwater Analytics Holdings, Inc. (0001866368) (Filer)

      5/2/25 4:10:16 PM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 15-12G filed by Enfusion Inc.

      15-12G - Enfusion, Inc. (0001868912) (Filer)

      5/1/25 4:15:29 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Clearwater Analytics Holdings, Inc. (0001866368) (Filer)

      4/30/25 4:10:22 PM ET
      $CWAN
      Computer Software: Prepackaged Software
      Technology
    • FTV Capital Named to Inc.'s Founder-Friendly Investors List for Fourth Consecutive Year

      FTV Capital, a leading sector-focused growth equity investment firm, today announced its inclusion for the fourth consecutive year on Inc.'s annual Founder-Friendly Investors list, which honors the private equity, venture capital firms and lenders with a track record of backing founder-led companies. This year's list recognizes 269 firms that believe in backing founder-led businesses and helping them thrive, demonstrated by their successful track records of collaboration and remaining actively involved with their portfolio companies to drive growth. "We are honored to be recognized again by Inc. for our ongoing commitment to serving as a collaborative, strategic partner to founders and ent

      10/29/24 7:00:00 AM ET
      $ENFN
      $GLOB
      Computer Software: Prepackaged Software
      Technology
      EDP Services
    • Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation

      Appointments of Arman Artuc to Head of Engineering, and Jesper Cordes to Head of Client Services Americas, Will Further Elevate Enfusion's Operations as an Investment Technology Industry Leader Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Artuc to Head of Engineering and Jesper Cordes to Head of Client Services Americas. These additions to the leadership team reinforce the company's position as a global leader in investment technology and services, which enables Enfusion to continue to attract top-performing industry experts and innovators to its ranks. Enfusion is s

      10/10/24 9:00:00 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • ZEMA Global Data Corporation to Acquire Morningstar Commodity Data

      Transformative acquisition will position ZEMA as global leader in offering high-quality enterprise data management and analytics for the energy and commodities industry ZEMA Global Data Corporation (formerly ZE PowerGroup), a leading provider of enterprise data management and analytics for the commodity and energy sectors, today announced its plans to acquire Morningstar Commodity Data, a provider of commodities and energy data and insights. The transaction is expected to close later this month. The business will serve a diverse portfolio of over 200 enterprises with an expanded product offering and broader geographic operations to support customers around the world. The announcement come

      9/23/24 8:00:00 AM ET
      $ENFN
      $GLOB
      Computer Software: Prepackaged Software
      Technology
      EDP Services